Latest AI and machine learning research in lung cancer for healthcare professionals.
Lung cancer exhibits strong heterogeneity, and its early diagnosis and precise subtyping are of great importance, as they can increase the ability to deliver personalized medicines by tailoring therapy regimens. Tissue biopsy, albeit the gold standard, is invasive, costly and provides limited information about the tumor and its molecular landscape. Exosomes, as promising biomarkers for lung cancer...
PURPOSE: Cone beam computed tomography-based online adaptive radiation therapy (ART) allows significantly smaller planning target volume margins for patients treated with adaptive stereotactic partial breast irradiation. However, this approach places increased demands on the treatment team, particularly physicians. We hypothesize that with appropriate training, physicians' involvement at the treat...
Human settlements on the Moon, crewed missions to Mars and space tourism will become a reality in the next few decades. Human presence in space, espec...
BACKGROUND: Non-small-cell lung cancer (NSCLC) and its surgery significantly increase the venous thromboembolism (VTE) risk. This study explored the V...
Individualized prediction of cancer drug sensitivity is of vital importance in precision medicine. While numerous predictive methodologies for cancer ...
PURPOSE: Accurate internal target volume (ITV) estimation is essential for effective and safe radiation therapy in liver cancer. This study evaluates ...
BACKGROUND: Radiation-induced esophagitis remains a significant challenge in thoracic and neck cancer treatment, impacting patient quality of life and...
The aim was to evaluate a deep learning-based auto-segmentation method for liver delineation in Y-90 selective internal radiation therapy (SIRT). A de...
PURPOSE: This study aims to develop an artificial intelligence model to predict severe radiation-induced oral mucositis (RIOM) in patients with locall...
Immunotherapy and chemoimmunotherapy are standard treatments for non-oncogene-addicted advanced non-small cell lung cancer (NSCLC). Currently, a limit...
Lung cancer, with its high mortality rate, is one of the deadliest diseases globally. The alarming increase in lung cancer deaths and its widespread p...
BACKGROUND: Accurate preoperative prediction of spread through air spaces (STAS) in primary lung adenocarcinoma (LUAD) is critical for optimizing surg...
The choice of imaging modalities is essential in sarcoma management, as different techniques provide complementary information depending on tumor subt...
OBJECTIVES: The growing adoption of Large Language Models (LLMs) in medicine has raised important questions about their potential utility for clinical...
INTRODUCTION: Tumor-infiltrating B lymphocytes (TILBs) play a pivotal role in shaping the immune microenvironment of tumors (TIME) and in the progress...
Colorectal cancer (CRC) ranks as the third most common and second deadliest cancer worldwide. The immune system, particularly tertiary lymphoid struct...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and highly aggressive, often leading to poor patient prognosis. Exist...
Nanomaterials represent an innovation in cancer imaging by offering enhanced contrast, improved targeting capabilities, and multifunctional imaging mo...
The American College of Veterinary Radiology (ACVR) and the European College of Veterinary Diagnostic Imaging (ECVDI) recognize the transformative pot...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers known to humans. However, not all patients fare equally poor survival, and a...